HomeCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Previous close
$210.29
Day range
$208.52 - $216.15
Year range
$166.87 - $275.00
Market cap
11.12B USD
Avg Volume
740.92K
P/E ratio
26.89
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 1.01B | -1.64% |
Operating expense | 231.62M | 11.16% |
Net income | 69.66M | -20.29% |
Net profit margin | 6.90 | -18.92% |
Earnings per share | 2.59 | -4.78% |
EBITDA | 205.60M | -16.62% |
Effective tax rate | 22.96% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 210.17M | 33.72% |
Total assets | 8.00B | 5.22% |
Total liabilities | 4.18B | -1.88% |
Total equity | 3.83B | — |
Shares outstanding | 51.13M | — |
Price to book | 2.84 | — |
Return on assets | 3.68% | — |
Return on capital | 4.45% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 69.66M | -20.29% |
Cash from operations | 251.79M | 22.56% |
Cash from investing | -21.32M | 73.20% |
Cash from financing | -207.54M | -27.43% |
Net change in cash | 30.64M | 170.98% |
Free cash flow | 207.35M | 105.15% |
About
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products, outsourcing services, and animals for research and development in the pharmaceutical industry and offers support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Its customers include leading pharmaceutical, biotechnology, agrochemical, government, and academic organization around the globe. The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories is often criticized by animal rights activists who condemn the company's usage of dogs and non-human primates for pharmaceutical purposes. The company is also a major harvester of horseshoe crab blood. Wikipedia
Founded
1947
Headquarters
Website
Employees
21,100